|
2026
|
P/S
|
Pharmaceutical preparations and substances. |
|
|
P/S
|
Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, re... |
|
|
P/S
|
Pharmaceutical preparations and substances. |
|
|
P/S
|
Pharmaceutical preparations for use in oncology; Pharmaceutical preparations and substances for t... |
|
2025
|
Invention
|
Conjugates comprising cleavable linkers. The specification relates to conjugates of Formula (I) a... |
|
|
Invention
|
Conjugates comprising linkers. The specification relates to conjugates comprising a linker of For... |
|
|
Invention
|
Combination of zibotentan and dapagliflozin for the treatment of chronic kidney disease and liver... |
|
|
Invention
|
Jak1 selective inhibitors.
Disclosed herein are compounds of Formula (I),
Disclosed herein are... |
|
|
Invention
|
Double-stranded rnai agents and compositions for reducing expression of angiopoietin-like 3 (angp... |
|
|
Invention
|
Substituted indazoles as irak4 inhibitors.
The present application relates to chemical compounds... |
|
|
Invention
|
Liquid-phase oligonucleotide synthesis using 2-(2-nitrophenyl)propyloxycarbonyl (nppoc) as a prot... |
|
|
Invention
|
Treatment of cancer with therapeutic binding molecules. A method of treating cancer in a subject ... |
|
|
Invention
|
Therapeutic combinations of an akt inhibitor, a bcl-2 inhibitor, and a glucocorticoid. Therapeuti... |
|
|
Invention
|
Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase ... |
|
|
Invention
|
Reusable auto-injector. Described herein is an auto-injector for receiving and operating a casset... |
|
|
Invention
|
Chemical compounds.
The present invention relates to azaquinolone compounds of Formula (I), and ... |
|
|
Invention
|
Carboxamide compounds as pkmyt1 inhibitors. Compounds having the structure of Formula (1) and pha... |
|
|
Invention
|
Quinazoline derivatives as gipr antagonists. The present specification relates to compounds of for... |
|
|
Invention
|
Improved cas9 proteins. The disclosure relates to a Cas9 protein comprising a polypeptide sequenc... |
|
|
Invention
|
Combination therapy comprising durvalumab and cisplatin/gemcitabine for use in treating bladder c... |
|
|
Invention
|
Methods, combinations, and uses for the treatment of muscle invasive bladder cancer.
The disclos... |
|
|
Invention
|
Dosage regimen for the treatment of cancer.
The present specification relates to AZD9833 for use... |
|
|
Invention
|
Therapies for wound treatment. The present specification concerns therapeutic approaches for the ... |
|
|
Invention
|
6-aminopurine derivatives useful as polq inhibitors. abb, X, Y, R1, R2, Q1, Q2, and Q3have any of... |
|
|
Invention
|
6-(cyclo)alkoxypurine derivatives useful as polq inhibitors. abb, X, Y, R1, R2, Q1, Q2, and Q3 ha... |
|
|
Invention
|
Methods for treating apol1-mediated kidney disease. The present disclosure provides methods for t... |
|
|
Invention
|
Combination therapy comprising azd0780 and ezetimibe. A method of lowering LDL-C levels, reducing... |
|
|
Invention
|
A spin chamber for an inhaler and an inhaler. A spin chamber (103) for use in an inhaler (200) in... |
|
|
Invention
|
A chimney shuttling mechanism for an inhaler. An inhaler (100, 200, 400) includes a main body (10... |
|
|
Invention
|
An inhaler. An inhaler (100, 200, 300, 400) includes a main body (101) and a drawer (102) to open... |
|
|
Invention
|
Keap1 inhibitors for use in the treatment of bronchiectasis. This specification describes Keap1 i... |
|
|
Invention
|
Conjugates comprising a topoisomerase i inhibitor. The specification relates to conjugates compri... |
|
|
Invention
|
Method of increasing time to second progression and time to first subsequent chemotherapy. The pr... |
|
|
Invention
|
Irak4 inhibitors.
The present application relates to chemical compounds of Formula (I), and phar... |
|
2024
|
Invention
|
Spin chamber for an inhaler.
A spin chamber for use in an inhaler includes a primary recess to r... |
|
|
Invention
|
Inhaler.
An inhaler includes a main body and a drawer to open out of and close into the main bod... |
|
|
Invention
|
Chimney shuttling mechanism for an inhaler.
An inhaler includes a main body having an inhalation... |
|
2023
|
Invention
|
Anti-ctla antibody compositions and related methods.
The present disclosure provides composition... |
|
|
Invention
|
Compositions and methods for treating advanced solid tumors.
Disclosed are methods for treating ... |
|
|
Invention
|
Combination of sglt2 inhibitors and mineralcorticoid receptor modulators for use in treatment of ... |
|
|
Invention
|
Mta-cooperative prmt5 inhibitors for use in the treatment of cancer.
The present specification r... |
|
|
Invention
|
Methods for detecting metabolites using a microfluidic-based ce-ms system.
The present disclosur... |
|
|
Invention
|
Anti-pcrv and psl bispecific antibodies for treatment of bronchiectasis.
This disclosure relates... |
|
|
Invention
|
N-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)-quinoline-4-carboxamides.
Compounds having the struct... |
|
|
Invention
|
Solid-state forms of n-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)-6-morpholinoquinoline-4-carboxami... |
|
|
Invention
|
Combination therapy for treating cancer.
The present provides a method of treating ovarian cance... |
|
|
Invention
|
Recombinant virus expressing interleukin-12.
The present disclosure relates to a recombinant pox... |
|
|
Invention
|
Rxfp1 modulators for treating resistant hypertension or heart failure with pulmonary hypertension... |
|
|
Invention
|
Combinations of rxfp1 modulators and sglt2 inhibitors.
The specification generally relates to co... |
|
|
Invention
|
Methods of treating melanoma using tebentafusp and immune checkpoint inhibitors.
The present inv... |
|
|
Invention
|
Combination of albuterol and budesonide for the treatment of asthma.
The present disclosure prov... |
|
|
Invention
|
T cell binding proteins.
The disclosure generally relates to binding proteins that comprise anti... |
|
2022
|
Invention
|
Therapeutic combinations of capivasertib and venetoclax.
Therapeutic combinations of capivaserti... |
